@article{487bd36f8d67425a818513975cfb7bdf,
title = "Slowly progressive Parkinson syndrome due to thalamic butterfly astrocytoma",
author = "T. W{\"a}chter and M. Engeholm and S. Bisdas and J. Schittenhelm and T. Gasser and R. Kr{\"u}ger",
note = "Funding Information: Disclosure: Dr. W{\"a}chter has received funding for travel and speaker honoraria from Medtronic, Inc., Solvay Pharmaceuticals, Inc., Abbott, Cephalon, Inc., and Schwarz Pharma; and holds stock in Gilead Sciences, Inc. Dr. Engeholm reports no disclosures. Dr. Bisdas serves on the editorial advisory board for Radiology Research and Practice. Dr. Schittenhelm has received research support from Merck Serono. Dr. Gasser serves on the editorial boards of Movement Disorders, Parkinsonism and Related Disorders, and the Journal of Neurology; holds a patent re: The LRRK2 gene and neurodegenerative disorders; serves as a consultant for Cephalon, Inc. and Merck Serono; serves on the speakers' bureaus of Novartis, Merck Serono, Schwarz Pharma, Boehringer Ingelheim, and Valeant Pharmaceuticals International; and receives research support from Novartis, the Federal Ministry of Education and Research (BMBF), the Helmholtz Association, and the European Union. Dr. Kr{\"u}ger has received speaker honoraria and/or funding for travel from UCB, Cephalon, Inc., Abbott, Takeda Pharmaceutical Company Limited, and Medtronic, Inc.; serves on the editorial advisory boards of the European Journal of Clinical Investigations, the Journal of Neural Transmission, and BMC Neurology; and receives research support from the German Research Council (DFG), the Michael J Fox Foundation, the Federal Ministry for Education and Research (BMBF), and the Medical Faculty of the University of T{\"u}bingen.",
year = "2011",
month = jul,
day = "26",
doi = "10.1212/WNL.0b013e3182267bc4",
language = "English",
volume = "77",
pages = "404--405",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",
}